CITANEST FORTE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Citanest Forte, and what generic alternatives are available?
Citanest Forte is a drug marketed by Astrazeneca and Dentsply Pharm and is included in two NDAs.
The generic ingredient in CITANEST FORTE is epinephrine bitartrate; prilocaine hydrochloride. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CITANEST FORTE?
- What are the global sales for CITANEST FORTE?
- What is Average Wholesale Price for CITANEST FORTE?
Summary for CITANEST FORTE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Clinical Trials: | 2 |
| What excipients (inactive ingredients) are in CITANEST FORTE? | CITANEST FORTE excipients list |
| DailyMed Link: | CITANEST FORTE at DailyMed |
Recent Clinical Trials for CITANEST FORTE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bozyaka Training and Research Hospital | Phase 4 |
| Diskapi Teaching and Research Hospital | Phase 4 |
US Patents and Regulatory Information for CITANEST FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | CITANEST FORTE | epinephrine bitartrate; prilocaine hydrochloride | INJECTABLE;INJECTION | 014763-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dentsply Pharm | CITANEST FORTE DENTAL | epinephrine bitartrate; prilocaine hydrochloride | INJECTABLE;INJECTION | 021383-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
